Home › Funds › Birchview Capital, LP › DRUG

Birchview Capital, LP position in DRUG

BRIGHT MINDS BIOSCIENCES INC · Health Care

Birchview Capital, LP reported holding 15,400 shares of DRUG (BRIGHT MINDS BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$767K, representing 0.46% of its reported portfolio and ranking #43 among its reported holdings. Birchview Capital, LP first reported this position in Q3 2026.

Latest position (Q3 2026)15.40K sh
Reported value held$767.23K
Portfolio Weight0.46%
First reportedQ3 2026
Last changeNew
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Birchview Capital, LP's DRUG position evolved

Birchview Capital, LP first disclosed a stake in DRUG in Q3 2026 at 15,400 shares (US$767K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 15.40K $767.23K New

About DRUG and 13F data

DRUG (BRIGHT MINDS BIOSCIENCES INC) is a Health Care company. 71 other funds we track also report a position in DRUG — the largest reported positions include Cormorant Asset Management, LP (US$63.2M), Vestal Point Capital, LP (US$38.3M), BRAIDWELL LP (US$34.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DRUG

All DRUG fund holders →

FAQ

How long has Birchview Capital, LP held DRUG?

Birchview Capital, LP has disclosed DRUG holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Birchview Capital, LP's current position in DRUG?

As of Q3 2026, Birchview Capital, LP holds 15.40K shares of DRUG (BRIGHT MINDS BIOSCIENCES INC), valued at $767.23K, representing 0.46% of its reported portfolio and ranking #43.

Has Birchview Capital, LP been buying or selling DRUG?

In the latest 13F filing (Q3 2026), Birchview Capital, LP newly opened its position in DRUG.

Which other funds hold DRUG?

Other major institutional holders of DRUG include Cormorant Asset Management, LP, Vestal Point Capital, LP, BRAIDWELL LP, among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.